Abbott, medical devices and health care company headquartered in Abbott Park, Illinois, has issued a recall for three of its leading baby formulas, including Similac, Alimentum, and EleCare. The recall was due to the discovery of cases where infants fell ill after consuming the milk brands.
According to Fox Business, the cases involve four infants in three states - Ohio, Texas, and Minnesota. The U.S. Food and Drug Administration stated that the powdered milk for infants was manufactured in Abbott Nutrition's Sturgis, Michigan facility.
The FDA is investigating the four cases that caused Cronobacter sakazakii and Salmonella Newport infections in the said regions. The babies were said to have been hospitalized, and there was one case of death where the FDA suspects that the Cronobacter may have contributed to the unfortunate incident.
In its recall announcement, the agency, along with U.S. Centers for Disease Control and Prevention, have warned and advised the public to refrain from buying certain Abbott powdered baby formulas that were made at the Sturgis, Michigan plant. It also mentioned that the investigation is still ongoing.
Moreover, the FDA is informing everyone to discard Similac, Alimentum, and EleCare baby milk formulas if the first two digits of the code are 22 to 37 and if the code on the container shows K8, SH, or Z2. The expiration date of the affected milk is April 1, 2022, or later.
At any rate, Abbott voluntarily recalled the affected products after receiving four complaints from the consumers. Then again, the company stressed that the recall is an isolated case and only affects powder formulas - Similac, Alimentum, and EleCare - that were made at its Sturgis, Michigan plant. The company further said that the liquid formulas or other Abbott nutrition powders are not included in the recall.
"We know parents depend on us to provide them with the highest quality nutrition formulas," Abbott's executive vice president, nutritional products, Joe Manning, said in a press release. "We are taking this action so parents know they can trust us to meet our high standards, as well as theirs. We deeply regret the concern and inconvenience this situation will cause parents, caregivers, and health care professionals."
Finally, the FDA Deputy Commissioner for Food Policy and Response, Frank Yiannas, said they are working to solve the safety concerns as soon as possible as they are aware of the severity of the issue.


Nissan Halts Electric Qashqai Development Amid EV Market Challenges
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi
Bessent Says U.S. Must Strengthen Supply Chains and Economic Security
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Australia Inflation Cools in May, But Core CPI Keeps RBA Rate Hike Risks Alive
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
Trump Requests $11 Billion More in Farm Aid as Rising Costs Pressure U.S. Farmers
Japan Manufacturing Growth Accelerates in June as Orders Surge Despite Iran War Cost Pressures
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal
Asian Stocks Slide as AI Rally Pauses, South Korean Chipmakers Lead Regional Decline
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
Oil Prices Drop as Strait of Hormuz Shipping Recovers
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 



